Synapsa

Synapsa is a brand name used for a proprietary standardized extract of the medicinal plant Ginkgo biloba, marketed as a dietary supplement for memory and cognitive support. It is one of several formulations available for consumer use and is commonly found in capsule or tablet form.

The extract is typically standardized to about 24 percent flavone glycosides and 6 percent terpene lactones, and is derived from the leaves of Ginkgo biloba. Such standardization aims to ensure consistency in the extract’s phytochemical profile across batches.

As a supplement, Synapsa is not approved as a medical treatment. It is marketed to support memory and general cognitive function rather than diagnose, treat, or cure any disease. Regulatory oversight and labeling requirements vary by country, and claims are typically limited to general wellness statements rather than therapeutic endorsements.

Clinical research on Synapsa-like Ginkgo extracts has yielded mixed results. Some studies report modest improvements in memory performance in older adults, while systematic reviews emphasize small, inconsistent effects and call for more rigorous trials. Differences in extract composition, study design, and participant characteristics contribute to variability in findings.

Safety considerations include potential gastrointestinal upset, headache, and dizziness. There is potential for interactions with anticoagulants and antiplatelet medications, which may increase bleeding risk. Use in pregnancy or lactation, or in people with bleeding disorders, should be discussed with a clinician. Quality control and product labeling can vary among brands.

See also: Ginkgo biloba.